Further research revealed that complex noncoding variants in TBX4 enhancer regions synergized with TBX4 coding mutations to exacerbate lung defects, leading to severe lung abnormalities and PAH.58, 59, 60. This evidence concerns the gene TBX4 and pulmonary arterial hypertension.